Princess Williams, MD
Surgical Oncology · Mooresville, NCNPI 1659692440
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.5%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.3%. 2025 is the largest year on record at $1,710, more than ten times the $17 reported in 2019.
Across 109 payments — averaging $78.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Hologic Inc$1K
- Novo Nordisk$800
- Myriad Genetic Laboratories, Inc.$741
- Carl Zeiss Meditec, Inc.$706
- Focal Therapeutics, Inc.$589
- plus $2K from 19 others
What the payments were for
- Travel & lodging$3,42840%
- Food & beverage$4,89157%
- Entertainment$1872%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,980 |
| Hologic Inc | 6 | $1,348 |
| Novo Nordisk | 27 | $800 |
| Myriad Genetic Laboratories, Inc. | 12 | $741 |
| Carl Zeiss Meditec, Inc. | 2 | $706 |
| Focal Therapeutics, Inc. | 3 | $589 |
| Integra Lifesciences Corporation | 9 | $501 |
| Merz North America, Inc. | 6 | $371 |
| Hologic Sales And Service, LLC | 4 | $326 |
| KUB Technologies Inc. | 2 | $310 |
| AstraZeneca | 3 | $263 |
| Seagen Inc. | 1 | $124 |
| Merck | 5 | $104 |
| Mentor Worldwide LLC | 1 | $92 |
| GE HealthCare | 2 | $50 |
| Tactile Systems Technology Inc | 2 | $40 |
| Merit Medical Systems Inc | 1 | $22 |
| Dilon Technologies, Inc. | 1 | $22 |
| Elucent Medical | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| TEI Biosciences Inc | 1 | $17 |
| Atland Pharmaceuticals, LLC | 1 | $16 |
| Davol Inc. | 1 | $16 |
| Molnlycke Health Care US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,506 in reported general payments places this provider in the 75th percentile of 34 surgical oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 92 | $274 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $107 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Mooresville
- Kristalyn GallagherChapel Hill$54K
- Georgia BeasleyDurham$23K
- Hong Jin KimChapel Hill$22K
- Akiko ChibaWinston Salem$14K
- Mark ArredondoHigh Point$13K
- Kevin ShahDurham$12K
- Allison MartinDurham$10K
- Jen Jen YehChapel Hill$8K
- Daniel NussbaumDurham$6K
- Benjamin DeschnerAsheville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.